Neurology Neuroimmunology & Neuroinflammation · 2019 · 63 citations · 5 references
Life SciencesImmunologyAutoimmunityClinical ImmunologyImmunopathologyAntibody CharacterizationAntibody ScreeningAntigen Detection AssaysAutoantibodiesAutoimmune BiomarkersAutoimmune Disease DiagnosticsCell-based AssaysCell-based Screening AssaysGaba-a Receptor Antibody-associated EpilepsyHek293 Cell ExpressionImmunofluorescence AssaysImmunofluorescence DiagnosisIndirect Fluorescent Antibody AssayIndirect Immunofluorescence Assay
<h3>Objective</h3> We sought to validate methods for detection and confirmation of GABA<sub>A</sub> receptor (R)-IgG and clinically characterize seropositive cases. <h3>Methods</h3> Archived serum and CSF specimens (185 total) suspected to harbor GABA<sub>A</sub>R-IgG were evaluated by indirect immunofluorescence assay (IFA). Twenty-six specimens from 19 patients appeared suspicious for GABA<sub>A</sub>R–IgG positivity by IFA, based on prior reports and comparison with commercial GABA<sub>A</sub>R antibody staining. Aliquots of those specimens were tested at the University of Oxford, United Kingdom, and Euroimmun, Lubeck, Germany, for GABA<sub>A</sub>R-IgG by cell-based assays (CBAs) using HEK293-indicator cells transfected with plasmids encoding different GABA<sub>A</sub>R subunits. <h3>Results</h3> Eight specimens (of 26 tested; 4 serums, 4 CSFs) from 5 patients were confirmed by CBA to be GABA<sub>A</sub>R-IgG positive. Patient IgGs were always reactive with α1β3 GABA<sub>A</sub>R subunits. One more patient was identified clinically after this validation study. Median age for the 6 patients at serologic diagnosis was 44 years (range, 1–71 years), and 4 of them were male. Among the 4 for whom clinical information was available (2 treated by the authors), all had encephalitis and antiepileptic drug refractory seizures. Three out of 4 patients treated with a combination of immunotherapies had good outcomes. The fourth, recognized to have an autoimmune cause late in the clinical course, had severe permanent neurologic sequelae and brain atrophy. <h3>Conclusions</h3> Though not as common as NMDA-R encephalitis, GABA<sub>A</sub>R encephalitis generally has a characteristic clinical-radiologic presentation and is treatable, making accurate laboratory diagnosis critical.
5
Mar Petit‐Pedrol, Thaís Armangué, Xiaoyu Peng et al. · The Lancet Neurology · 2014 · 615 citations · Full text
Medicine, Neurology, Neuroscience +17
Investigations in GABA <sub>A</sub> receptor antibody-associated encephalitis
Marianna Spatola, Mar Petit‐Pedrol, Mateus Mistieri Simabukuro et al. · Neurology · 2017 · 330 citations · Full text
Medicine, Neurology, Neuroscience +17
Yael Hacohen, Sukhvir Wright, Patrick Waters et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 262 citations · Full text
Medicine, Neurology, Pediatrics +17